Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 25 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/15/19
End: 01/01/32
Due: 01/01/33
Phase: N/A
Priority: Normal
Start: 06/16/17
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 04/04/19
End: 04/30/30
Due: 04/30/31
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 12/21/21
Due: 12/21/22
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 11/30/28
Due: 11/30/29
Phase: N/A
Priority: Normal
Start: 03/27/19
End: 12/31/32
Due: 12/31/33
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 12/31/17
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 04/11/18
End: 06/18/22
Due: 06/18/23
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 10/21/20
End: 11/01/33
Due: 11/01/34
Phase: N/A
Priority: Normal
Start: 09/30/20
End: 11/01/33
Due: 11/01/34
Phase: N/A
Priority: Normal
Start: 03/09/17
End: 08/24/20
Due: 08/24/21
Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur
Phase: N/A
Priority: Normal
Start: 02/03/20
End: 08/31/32
Due: 08/31/33
Phase: N/A
Priority: Normal
Start: 10/31/23
End: 12/31/36
Due: 12/31/37
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 12/20/21
Due: 12/20/22
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 07/13/16
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 01/27/22
End: 01/31/35
Due: 01/31/36
Phase: N/A
Priority: Normal
Start: 12/31/21
End: 12/31/33
Due: 12/31/34
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 06/15/15
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 09/04/15
End: 10/31/27
Due: 10/31/28